A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome

NCT05898620 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
33
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Neurogene Inc.